Core Laboratories (CLB-8.4%) plunges after suffering a round of stock price target cuts at several side sell firms in the wake of last week's Q2 earnings report. Morgan Stanley trimmed its price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback